| 2017-05-16 06:36:06 | Boston Scientific initiated with a Neutral at Goldman SachsGoldman Sachs analyst Isaac Ro started Boston Scientific with a Neutral rating and $28 price target. The analyst views the company's "solid" growth as fairly valued. | |
|---|---|---|
| ||
| , … |
| |
|---|---|---|
| ||
| | |
| | |
| |
| | |
| ||
| | |
| , |
| |
| , |
| |
| ||
| | |
| , … |
| |
| , |
| |
| |
| , … |
| |
|---|---|---|
| | |
| | |
| ||
| |
| | |
| , |
| |
| ||
| ||
|